| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |